SecSonar.com

iRhythm Technologies, Inc. (IRTC)

iRhythm Technologies, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

iRhythm Technologies, Inc. (IRTC) is a Medical - Devices company based in US with a market capitalization of $3.8B. Revenue grew 26.2% year-over-year and the company generated $34.5M in free cash flow. This page tracks IRTC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2K employees · IPO Oct 20, 2016

Valuation

Valuation & price

$114.00 · as of May 17, 2026 · -39.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

24.76

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$189$146$102Jul 25Dec 25Jul 26Jul 7, 25$139.22Jul 9, 25$132.88Jul 11, 25$135.94Jul 15, 25$133.92Jul 17, 25$135.76Jul 21, 25$135.52Jul 23, 25$134.63Jul 25, 25$134.18Jul 29, 25$136.77Jul 31, 25$140.18Aug 4, 25$164.98Aug 6, 25$156.02Aug 11, 25$160.56Aug 13, 25$166.86Aug 15, 25$160.58Aug 19, 25$158.52Aug 21, 25$166.68Aug 25, 25$165.68Aug 27, 25$169.79Aug 29, 25$169.98Sep 3, 25$176.58Sep 5, 25$181.05Sep 9, 25$186.39Sep 11, 25$181.03Sep 16, 25$174.40Sep 18, 25$176.40Sep 22, 25$184.73Sep 24, 25$173.93Sep 26, 25$170.81Sep 30, 25$171.99Oct 2, 25$173.81Oct 6, 25$175.75Oct 8, 25$179.00Oct 10, 25$176.20Oct 14, 25$176.84Oct 16, 25$181.02Oct 21, 25$178.18Oct 23, 25$182.27Oct 27, 25$182.71Oct 29, 25$185.29Oct 31, 25$187.30Nov 4, 25$181.10Nov 6, 25$177.40Nov 10, 25$176.30Nov 12, 25$179.12Nov 14, 25$170.82Nov 18, 25$169.67Nov 20, 25$169.70Nov 25, 25$188.30Nov 28, 25$188.01Dec 2, 25$181.87Dec 4, 25$181.35Dec 8, 25$173.33Dec 10, 25$172.37Dec 12, 25$168.83Dec 16, 25$167.90Dec 18, 25$168.48Dec 22, 25$179.65Dec 24, 25$175.80Dec 29, 25$178.60Jan 2, 26$175.22Jan 6, 26$184.98Jan 8, 26$189.25Jan 12, 26$168.99Jan 14, 26$163.24Jan 16, 26$167.16Jan 21, 26$163.65Jan 23, 26$160.34Jan 27, 26$156.56Jan 29, 26$148.99Feb 2, 26$155.73Feb 4, 26$152.46Feb 9, 26$148.50Feb 11, 26$152.11Feb 13, 26$144.21Feb 18, 26$153.85Feb 20, 26$150.96Feb 24, 26$137.10Feb 26, 26$140.18Mar 2, 26$128.46Mar 4, 26$127.95Mar 6, 26$123.59Mar 10, 26$120.53Mar 12, 26$114.67Mar 17, 26$117.53Mar 19, 26$117.78Mar 23, 26$118.14Mar 25, 26$121.79Mar 27, 26$118.10Mar 31, 26$118.02Apr 2, 26$116.80Apr 7, 26$118.63Apr 9, 26$118.16Apr 13, 26$120.45Apr 15, 26$124.41Apr 17, 26$125.32Apr 22, 26$121.95Apr 24, 26$122.35Apr 28, 26$125.44Apr 30, 26$129.16May 4, 26$119.18May 6, 26$117.70May 8, 26$120.66May 12, 26$118.31May 14, 26$114.16May 18, 26$110.94May 20, 26$117.00May 22, 26$116.56May 28, 26$115.61Jun 1, 26$109.17Jun 3, 26$104.56Jun 5, 26$108.11Jun 9, 26$113.83Jun 11, 26$112.67Jun 15, 26$113.76Jun 17, 26$101.79Jun 22, 26$104.69Jun 24, 26$112.47Jun 26, 26$118.89Jul 2, 26$126.57
$101.7952-week range$189.25
Loading valuation history…

Fundamentals

Key fundamentals

$3.8B

Market cap

26.2%

Revenue growth (YoY)

70.6%

Gross margin

$34.5M

Free cash flow (USD)

$147.4M

Net debt

2.6%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$64.1MFY 2017$99.1MFY 2018$147.3MFY 2019$214.6MFY 2020$265.2MFY 2021$322.8MFY 2022$410.9MFY 2023$492.7MFY 2024$591.8MFY 2025$747.1M
$64.1M$747.1M

Free cash flow by year

2016 → 2025

FY 2016$-19.4MFY 2017$-18.5MFY 2018$-34.2MFY 2019$-42.3MFY 2020$-27.3MFY 2021$-65.8MFY 2022$-52.8MFY 2023$-90.5MFY 2024$-30.6MFY 2025$34.5M
-$19.4M$34.5M

Gross margin by year

2021 → 2025

FY 202166.2%FY 202268.5%FY 202367.3%FY 202468.9%FY 202570.6%
66.2%70.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

4

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCybersecurity IncidentJun 15, 2026Filing
  • 8-K eventSettlement AgreementJun 5, 2026Filing
  • Insider sellInsider Sell $79KRosenbaum Marc Wade · Chief Accounting Officer · $78.9KJun 3, 2026Filing
  • Insider sellInsider Sell $186KShrishrimal Sumi · EVP, Chief Risk Officer · $185.7KJun 3, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 28, 2026Filing
  • Insider sellInsider Sell $626K · 10b5-1 PlanTALWALKAR ABHIJIT Y · Director · $626.4KMay 12, 2026Filing
  • Insider sellInsider Sell $122KLawrence Brian Lee · Chief Technology Officer · $122.5KMay 5, 2026Filing
  • 8-K eventEarnings ReleaseApr 30, 2026Filing
  • Quarterly report10-Q FiledApr 30, 2026Filing
  • 8-K eventAccounting Firm ChangeApr 1, 2026Filing

Questions

Frequently asked questions

What is iRhythm Technologies, Inc.'s market cap?

iRhythm Technologies, Inc. (IRTC) has a market capitalization of $3.8B.

What is IRTC's P/E ratio?

A meaningful P/E ratio is not available for IRTC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is IRTC's price-to-book (P/B) ratio?

IRTC trades at 24.76 times book value per share.

Are insiders buying IRTC stock?

SEC Form 4 filings show no open-market insider buys at iRhythm Technologies, Inc. in the last 90 days (4 sells).

Same arena

Related companies in Medical - Devices

LIVN

LivaNova PLC

$4B

ITGR

Integer Holdings Corporation

$3.1B

TMDX

TransMedics Group, Inc.

$2.3B

ESTA

Establishment Labs Holdings Inc.

$2.1B

AXGN

AxoGen, Inc.

$2.1B

UFPT

UFP Technologies, Inc.

$1.7B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.